Fumiaki Kiyomi
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema.
Journal: Respirology (Carlton, Vic.)
Published: February 04, 2026
Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study).
Journal: Cancer treatment and research communications
Published: July 29, 2025
Prognostic impact of muscle mass in idiopathic interstitial pneumonia: analysis of idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias.
Journal: BMC pulmonary medicine
Published: May 21, 2025
Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis.
Journal: Respirology (Carlton, Vic.)
Published: August 28, 2024
Nivolumab plus ipilimumab with chemotherapy for non-small cell lung cancer with untreated brain metastases: A multicenter single-arm phase 2 trial (NIke, LOGiK 2004).
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 15, 2024
Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.
Journal: BMC pulmonary medicine
Published: March 08, 2024
Usefulness of virtual scale endoscope for early gastrointestinal lesions.
Journal: DEN open
Published: February 08, 2024
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 08, 2023
Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trial.
Journal: Cancer medicine
Published: March 07, 2023
A protocol of a single arm, prospective, open-label, multicenter, phase II study of ramucirumab and erlotinib in treatment-naïve non-small cell lung cancer patients with EGFR mutation and brain metastases (SPIRAL-BRAIN study).
Journal: Translational lung cancer research
Published: February 23, 2023
Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial.
Journal: European journal of medical research
Published: February 15, 2023
Last Updated: 09/26/2026